Literature DB >> 7235675

In vitro antagonism by erythromycin of the bactericidal action of antimicrobial agents against common respiratory pathogens.

J R Cohn, D L Jungkind, J S Baker.   

Abstract

Ten strains each of Staphylococcus aureus, Haemophilus influenzae, Enterobacter spp., Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, and Streptococcus pneumoniae were tested in vitro against erythromycin combined with ampicillin, cefamandole, or gentamicin. Antagonism by erythromycin occurred with 47% of the combinations involving strains of S. aureus and to a lesser degree with H. influenzae. Synergy occurred most commonly with H. influenzae (27%). The high frequency of antagonism and synergy with these organisms was associated with a broad range of bacteriostatic action by erythromycin against these same bacteria. The implications for the treatment of pneumonia are discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7235675      PMCID: PMC352981          DOI: 10.1128/AAC.18.6.872

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  16 in total

1.  A laboratory test for bacterial sensitivity to combinations of antibiotics.

Authors:  E JAWETZ; J B GUNNISON; V R COLEMAN; H C KEMPE
Journal:  Am J Clin Pathol       Date:  1955-09       Impact factor: 2.493

2.  Treatment of pneumococcic meningitis with penicillin compared with penicillin plus aureomycin; studies including observations on an apparent antagonism between penicillin and aureomycin.

Authors:  M H LEPPER; H F DOWLING
Journal:  AMA Arch Intern Med       Date:  1951-10

3.  Emergence of multiply resistant pneumococci.

Authors:  M R Jacobs; H J Koornhof; R M Robins-Browne; C M Stevenson; Z A Vermaak; I Freiman; G B Miller; M A Witcomb; M Isaäcson; J I Ward; R Austrian
Journal:  N Engl J Med       Date:  1978-10-05       Impact factor: 91.245

4.  Mechanism of penicillin-erythromycin synergy on antibiotic-resistant Staphylococcus aureus.

Authors:  N E Allen; J K Epp
Journal:  Antimicrob Agents Chemother       Date:  1978-05       Impact factor: 5.191

5.  Rapid diagnosis of Legionnaires' disease by direct immunofluorescent staining.

Authors:  C V Broome; W B Cherry; W C Winn; B R MacPherson
Journal:  Ann Intern Med       Date:  1979-01       Impact factor: 25.391

6.  Bacteriology and treatment of primary lung abscess.

Authors:  J G Bartlett; S L Gorbach; F P Tally; S M Finegold
Journal:  Am Rev Respir Dis       Date:  1974-05

7.  A study of the combined role of viruses, mycoplasmas and bacteria in adult pneumonia.

Authors:  M Fiala
Journal:  Am J Med Sci       Date:  1969-01       Impact factor: 2.378

8.  The role of viruses, mycoplasmas and bacteria in acute pneumonia in civilian adults.

Authors:  M A Mufson; V Chang; V Gill; S C Wood; M J Romansky; R M Chanock
Journal:  Am J Epidemiol       Date:  1967-11       Impact factor: 4.897

9.  Legionnaires' disease: description of an epidemic of pneumonia.

Authors:  D W Fraser; T R Tsai; W Orenstein; W E Parkin; H J Beecham; R G Sharrar; J Harris; G F Mallison; S M Martin; J E McDade; C C Shepard; P S Brachman
Journal:  N Engl J Med       Date:  1977-12-01       Impact factor: 91.245

10.  Legionnaires' disease: clinical features of 24 cases.

Authors:  B D Kirby; K M Snyder; R D Meyer; S M Finegold
Journal:  Ann Intern Med       Date:  1978-09       Impact factor: 25.391

View more
  3 in total

1.  Lack of bactericidal antagonism or synergism in vitro between oxacillin and vancomycin against methicillin-susceptible strains of Staphylococcus aureus.

Authors:  Christian Joukhadar; Satish Pillai; Christine Wennersten; Robert C Moellering; George M Eliopoulos
Journal:  Antimicrob Agents Chemother       Date:  2009-11-23       Impact factor: 5.191

2.  Effects of erythromycin in combination with penicillin, ampicillin, or gentamicin on the growth of Listeria monocytogenes.

Authors:  R L Penn; T T Ward; R T Steigbigel
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

3.  Erythromycin (2 X 1 g) as a Regimen for community-acquired pneumonia.

Authors:  H P Simmen; R Lüthy
Journal:  Infection       Date:  1982       Impact factor: 3.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.